Arming oncolytic viruses to leverage antitumor immunity

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)959-971
JournalExpert Opinion on Biological Therapy
Volume15
Issue number7
DOIs
Publication statusPublished - 2015

Cite this

@article{be32e0aa53104a188fb35ecc1efc0351,
title = "Arming oncolytic viruses to leverage antitumor immunity",
author = "{de Gruijl}, T.D. and A.B. Janssen and {van Beusechem}, V.W.",
year = "2015",
doi = "10.1517/14712598.2015.1044433",
language = "Undefined/Unknown",
volume = "15",
pages = "959--971",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Taylor and Francis Ltd.",
number = "7",

}

Arming oncolytic viruses to leverage antitumor immunity. / de Gruijl, T.D.; Janssen, A.B.; van Beusechem, V.W.

In: Expert Opinion on Biological Therapy, Vol. 15, No. 7, 2015, p. 959-971.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Arming oncolytic viruses to leverage antitumor immunity

AU - de Gruijl, T.D.

AU - Janssen, A.B.

AU - van Beusechem, V.W.

PY - 2015

Y1 - 2015

U2 - 10.1517/14712598.2015.1044433

DO - 10.1517/14712598.2015.1044433

M3 - Article

VL - 15

SP - 959

EP - 971

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 7

ER -